End‐Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants

End‐Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants. Introduction: Patients with chronic kidney disease (CKD) have increased morbidity following invasive procedures. We hypothesized that patients with CKD have higher complication rates following device implantation than patients with normal renal function.

[1]  Alexander H Maass,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.

[2]  David D Spragg,et al.  Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. , 2010, Journal of the American College of Cardiology.

[3]  Walter R Wilson,et al.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. , 2010, Circulation.

[4]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[5]  C. Love,et al.  In Vivo Model of Human Pathogen Infection and Demonstration of Efficacy by an Antimicrobial Pouch for Pacing Devices , 2009, Pacing and clinical electrophysiology : PACE.

[6]  G. Remuzzi,et al.  Treatment of Bleeding in Dialysis Patients , 2009, Seminars in dialysis.

[7]  S. Silverman,et al.  From randomized controlled trials to observational studies. , 2009, The American journal of medicine.

[8]  S. A. D’Orio Nishioka,et al.  Efficacy of Antibiotic Prophylaxis Before the Implantation of Pacemakers and Cardioverter-Defibrillators: Results of a Large, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial , 2009, Circulation. Arrhythmia and electrophysiology.

[9]  A. Budaj,et al.  Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). , 2009, JACC. Cardiovascular interventions.

[10]  Y. Yuzawa,et al.  Aspects of immune dysfunction in end-stage renal disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[11]  O. Bonnín,et al.  Effect of preoperative mild renal dysfunction on mortality and morbidity following valve cardiac surgery. , 2007, Interactive cardiovascular and thoracic surgery.

[12]  J. Ornato,et al.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.

[13]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[14]  E. Antman,et al.  The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. , 2007, Journal of the American College of Cardiology.

[15]  S. Saba,et al.  Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. , 2006, Journal of the American College of Cardiology.

[16]  C. Cannon,et al.  Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. , 2006, Journal of the American College of Cardiology.

[17]  D. Hodge,et al.  P1-57: Pacemaker and ICD infections: Risk factor analysis using a case-control study , 2006 .

[18]  D. Delurgio,et al.  Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery , 2006, Pacing and clinical electrophysiology : PACE.

[19]  S. Goldhaber.  Low Intensity Warfarin Anticoagulation is Safe and Effective as a Long-Term Venous Thromboembolism Prevention Strategy , 2006, Journal of Thrombosis and Thrombolysis.

[20]  M. Crowther,et al.  Bleeding in patients with renal insufficiency: a practical guide to clinical management. , 2006, Thrombosis research.

[21]  N. Freemantle,et al.  Relation Between Mild Renal Dysfunction and Outcomes After Coronary Artery Bypass Grafting , 2005, Circulation.

[22]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[23]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[24]  Valentin Fuster,et al.  AHA/ACC Scientific StatementAmerican Heart Association/American College of Cardiology Foundation guide to warfarin therapy1 , 2003 .

[25]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[26]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[27]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  H. Halperin,et al.  Prospective Randomized Comparison of the Safety and Effectiveness of Placement of Endocardial Pacemaker and Defibrillator Leads Using the Extrathoracic Subclavian Vein Guided by Contrast Venography Versus the Cephalic Approach , 2001, Pacing and clinical electrophysiology : PACE.

[30]  B. Jaber,et al.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. , 2000, Kidney international.

[31]  F. Logerfo,et al.  Renal insufficiency and altered postoperative risk in carotid endarterectomy. , 1999, Journal of vascular surgery.

[32]  Robert J. Anderson,et al.  Clinical Nephrology – Epidemiology – Clinical TrialsRenal failure predisposes patients to adverse outcome after coronary artery bypass surgery , 1999 .

[33]  Thomas E. Moritz,et al.  Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery , 1999 .

[34]  A. Pavie,et al.  Pacemaker infective endocarditis. , 1998, The American journal of cardiology.

[35]  B. Hoen,et al.  EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. , 1998, Journal of the American Society of Nephrology : JASN.

[36]  K Isaaz,et al.  Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. , 1998, Circulation.

[37]  E. Cook,et al.  Preoperative renal risk stratification. , 1997, Circulation.

[38]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[39]  J. Montgomerie,et al.  RENAL FAILURE AND INFECTION , 1968, Medicine.

[40]  J. H. Ferguson,et al.  Bleeding tendency in uremia. , 1956, Blood.